Renée Fuller focuses her practice on patent prosecution in areas related to chemistry and materials science. Renée’s scientific background includes biochemistry, biomaterials, biomedical engineering, diagnostics, drug delivery systems, medical devices, nanotechnology, polymer chemistry, surface science, and semiconductor fabrication.
Prior to joining Wolf Greenfield, Renée conducted postdoctoral research at Harvard University with Professor George Whitesides, where she developed tools for cancer diagnosis and designed low cost diagnostics for resource-limited settings. Her diagnostics work focused on bacteria detection and immunoassays utilizing bacteriophage and enzyme-based readout systems. Renée received her doctorate degree in Chemistry and Biomedical Engineering at MIT under the supervision of Professor Paula Hammond. Her doctoral research focused on the design and fabrication of biomedical devices to release pharmaceuticals after device implantation for the treatment of disease. In her research, Renée used surface chemistry and self-assembly techniques to add drug delivery systems to device surfaces without compromising device functionality. Specifically, her research included the design and synthesis of biodegradable polymers, the development of ultrathin polymer film systems, and the fabrication and biocompatibility testing of pharmaceutical-releasing intraocular lenses, orthopedic implants, and bandages. As part of her doctoral work, Renée completed a year of preclinical training at Harvard Medical School and several clerkships in medicine.
Renée has co-authored several publications in peer-reviewed journals and is a co-inventor of several pending patents.